Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate augmentation in OCD
NCT02194075Phase 4Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in obsessive compulsive disorder (OCD), sponsored by Guangdong Provincial People's Hospital. Started Oct 2013; status: completed.
02
Drugs
methylphenidate
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT02194075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194075.